U.S. Wireless Telecom Stock News

LifeVantage Corporation ( NASDAQ:LFVN ) shareholders are probably feeling a little disappointed, since its shares fell...

Array has teamed up with Narmi to integrate comprehensive financial tools directly into digital banking platforms, marking a significant development in the digital payments landscape. This collaboration enables financial institutions to seamlessly offer tools for credit monitoring, identity protection, and financial management within the trusted banking interface. The partnership aims to enhance user engagement and loyalty by providing consumers with advanced financial empowerment solutions...

Intel (NasdaqGS: INTC) is identified as a key vendor in the global 5G edge cloud network and services market in a new independent report. The report forecasts significant market growth through 2030, citing AI inference at the edge and private 5G for Industry 4.0 as central demand drivers. Intel is highlighted for its role in supporting ultra low latency, regulatory aligned edge infrastructure that goes beyond core data center and on premises enterprise AI use cases. To put Intel's 5G edge...

Central banks are sending hawkish signals as they assess inflation risks, while AI related debt issuance grows and keeps investors focused on the scale of this shift. That combination keeps attention on companies tied directly to the ChatGPT and AI story. This article highlights three stocks from our AI Stocks screener that sit at the intersection of chips, cloud and software so you can see where some investors are focusing capital. The stocks covered below are only a starting sample from...

Camtek Stock Performance Snapshot After Recent Moves Camtek (CAMT) has drawn fresh attention after recent share price moves, with the stock closing at US$135.57 on the latest trading day. Investors are weighing this level against its mixed short term and longer term return profile. Over the past day the stock declined 6.38%, and it is down 4.75% over the past week. Over the past month Camtek has a gain of 2.35%, while over the past 3 months the stock has fallen 27.70%, highlighting shifting...

In August 2026, Alibaba Group Holding completed an HK$80.02 billion follow-on offering of 710 million Hong Kong-listed ordinary shares at HK$112.70 each, shortly after disclosing weaker quarterly earnings and extensive share repurchases. The company plans to channel these fresh funds into global AI and cloud infrastructure just as insiders, including Jack Ma, Joe Tsai, and Eddie Wu, increased their holdings, highlighting management’s commitment to its AI-focused transformation despite...

On August 27, 2026, Applied Materials added Qualcomm CFO and COO Akash Palkhiwala to its Board of Directors and Audit Committee, bringing deep experience in semiconductor finance, operations and global go-to-market execution. His background overseeing Qualcomm’s semiconductor operations and IT may strengthen Applied Materials’ governance and oversight as AI-related chip investments and complexity increase. Next, we’ll examine how Akash Palkhiwala’s appointment to the board could influence...

In the second quarter of 2026, Hesai Group reported CNY 860.83 million in sales and CNY 70.55 million in net income, alongside strong year-to-date growth in revenue and earnings per share versus the prior year. At the same time, the company issued third-quarter 2026 revenue guidance of RMB 1,100 million to RMB 1,150 million, signaling confidence in its near-term operating momentum and demand visibility. We will now examine how this earnings beat and confident third-quarter revenue guidance...

Extra Space Storage stock has delivered a 25.6% gain over the past three years, while current valuation checks show a mixed picture as the intrinsic value estimate suggests the shares trade below that level and market multiples look closer to fair. Recent share price softness over the past month and week adds another layer for investors who are trying to judge whether that gap offers opportunity or simply reflects caution around the outlook. The 25.6% return over three years points to a...

How ADT Stock Has Been Performing Recently ADT (ADT) has seen mixed share price moves in recent periods, including a gain over the past week and declines over the past month and past year. This context may shape how investors view the stock today. Over the past week, ADT has gained about 1.6%. That follows a move higher of roughly 1.1% in the last trading day. The stock is down about 1.3% over the past month and about 10.8% over the past year. ADT’s recent 1.1% one day and 1.6% seven day...

Goodyear Tire & Rubber (NasdaqGS:GT) has extended its turnaround timeline as it works through business restructuring and financial targets. The revised timeframe reflects ongoing pressures from tariffs, higher raw material costs and growing competition from lower priced imports. Management plans to keep reshaping operations and cost structures as part of the longer turnaround effort. This kind of reset is not unique to Goodyear. It can be useful to compare how other companies exposed to...

Biohaven (BHVN) drew fresh investor attention after announcing a global licensing and collaboration agreement that gives SK Biopharmaceuticals exclusive worldwide rights to its Kv7 ion channel platform, led by opakalim for focal epilepsy. The announcement arrives after a strong run in Biohaven’s share price, with a 90 day share price return of 52.12% and a year to date share price return of 42.16%, while the 1 year total shareholder return is roughly flat at 0.13%. Scan how licensing driven...

Rising oil prices are feeding into inflation pressures in several regions, which keeps central banks focused on interest rates and highlights the importance of sectors tied to government and security spending. In that context, screens such as Aerospace And Defense are on the radar for investors who want exposure to companies linked to long term public budgets. This article walks through three stocks from the screener that may merit a closer look at this time. The three Aerospace And Defense...

Why the CFO transition at GE Vernova matters for investors GE Vernova (GEV) is reshaping its finance leadership as Kenneth Parks plans to retire as CFO in April 2027 and Claire McDonough, currently Rivian Automotive's CFO, prepares to succeed him. The transition starts with McDonough joining as a strategic advisor in November 2026, overlapping with Parks through his advisory role from January 2027. For you as an investor, the focus is how this affects capital allocation, balance sheet...

In August 2026, Cellebrite DI Ltd. launched its rugged Cellebrite Tactical Extraction Kit (C-TEK) for real-time, in-field mobile forensics and expanded its AI-powered Genesis investigation platform to additional global public sector and enterprise customers. Together, these moves deepen Cellebrite’s reach into defense and corporate investigations, signaling a push to bring its digital intelligence tools closer to the edge of operations worldwide. We’ll now explore how extending Genesis into...

Frontier AI is now on the radar of central banks, with the Bank of England warning that smarter algorithms could mean smarter cyberattacks on payments, trading and cloud systems that keep markets running. For investors, that raises both risk and opportunity, as trust in financial plumbing becomes even more valuable. This article walks through 3 stocks from our screener that are exposed to these AI driven security themes. The stocks in the article below are only a starting sample, and the full...

Kyndryl Holdings alliance news and why it matters for stock watchers Kyndryl Holdings (KD) has expanded its alliance with Broadcom to provide end-to-end consulting for VMware Cloud Foundation. The move focuses on AI-ready private clouds, security, automation and skills investment for several thousand consultants. For context, Kyndryl Holdings’ share price is at US$13.20, with a 7 day share price return of 3.53% and a 90 day share price return of 4.76%. This contrasts with a year to date share...

Silicon Laboratories has surged year to date, but the valuation signals are pulling in different directions, with an intrinsic value estimate suggesting the stock may be cheap while market based multiples lean the other way. Silicon Laboratories is up 65.6% year to date, so anyone looking at the stock today is dealing with a very different entry point than at the start of the year. Expectations for continued cash flow generation from its mixed signal and connectivity products can support the...

AbbVie (NYSE: ABBV) has submitted an application to the European Medicines Agency for a subcutaneous SKYRIZI induction regimen in Crohn's disease, backed by Phase 3 AFFIRM trial results. The filing seeks to expand SKYRIZI's approved use to cover induction therapy delivered via subcutaneous injection rather than intravenous infusion. Positive Phase 3 AFFIRM data form the clinical basis for the submission, supporting the potential for a less invasive induction option for eligible Crohn's...

Earlier in August 2026, Kohl’s raised its full-year earnings guidance while still projecting net and comparable sales to range from a 1.5% decline to flat, and it affirmed its regular quarterly dividend of US$0.125 per share. Alongside this, the retailer expanded its assortment with Martha Stewart kitchen electrics, joined DoorDash’s retail marketplace, and elevated former Chief Digital Officer Arianne Parisi to the new Chief Customer Officer role to sharpen its omnichannel offering. We’ll...

Nebius Group (NasdaqGS:NBIS) is back in focus after a strong second quarter, with AI infrastructure revenue and large contracts drawing attention to how the company is using capital and what that might mean for the stock. Nebius Group’s share price has had a volatile year, with a 1 month share price return of 9.86% and a year to date share price return of 132.55%, even after a 19.73% decline over the past 90 days and a 4.26% drop in the last session. That kind of swing has kept attention on...

Fresh look at Bio-Rad Laboratories after recent share price move Bio-Rad Laboratories (BIO) has drawn fresh investor attention after a recent share price move, with the stock closing at $387.70. That puts current performance in focus across its life science and clinical diagnostics segments. Over the past month, Bio-Rad Laboratories has shown stronger momentum, with a 30 day share price return of 19.12% and a year to date share price return of 27%. However, the 5 year total shareholder return...

Over the last 7 days, the United States market has remained flat, yet it has experienced an impressive 18% increase over the past year with earnings forecasted to grow by 17% annually. In this environment, identifying small-cap stocks that are potentially undervalued and exhibit insider activity can offer unique opportunities for investors seeking to capitalize on future growth.

Over the last 7 days, the United States market has remained flat, yet it has seen an impressive 18% increase over the past year with earnings forecast to grow by 17% annually. In this environment, identifying stocks that are trading below their intrinsic value can offer investors potential opportunities for growth and resilience.